A previous study has suggested that atrial natriuretic peptide (ANP) alters arterial baroreflex control of lumbar and renal sympathetic nerve activity. To explore these mechanisms, we examined the interrelationship of arterial pressure, afferent aortic nerve activity, and aortic diameter in rabbits anesthetized with a-chloralose before and after sinoaortic denervation and bilateral vagotomy. Arterial pressure was decreased in stepwise fashion by intravenous infusion of a-human ANP (a-hANP, 0.1-1.0 /tg/kg/min) or sodium nitroprusside (SNP, 1-5 /xg/kg/ min). Both in rabbits with intact baroreceptors and in those with baroreceptors denervated, aortic nerve activity and the aortic diameter decreased during hypotension caused by the infusion of SNP but remained unchanged during hypotension caused by the infusion of a-hANP. In addition, we examined the effects of a-hANP and SNP on the responses of the aortic diameter and aortic nerve activity to rapid changes in arterial pressure caused by intravenous phenylephrine or nitroglycerin. Changes in aortic nerve activity and the aortic diameter in response to rapid changes in arterial pressure caused by phenylephrine or nitroglycerin were not different between the infusion of a-hANP and SNP. These results suggest that aortic nerve activity remains unchanged despite hypotension during the infusion of a-hANP, because a-hANP dilates the aorta. Since the aortic diameter increases, strain of aortic baroreceptors does not decrease. A second suggestion is that a-hANP does not alter aortic baroreceptor responses to changes in arterial pressure caused by phenylephrine or nitroglycerin. (Circulation Research 1988;63:987-996)
I t is suggested that atrial natriuretic peptide (ANP) plays an important role in body fluid homeostasis. 12 ANP has vasorelaxant and depressor effects as well as renal effects. '-4 In addition, recent studies have suggested that ANP may influence control of sympathetic nerve activity. 5 -' 2 It has been shown that renal and lumbar sympathetic nerve activity may be inhibited or unchanged during hypotension caused by ANP in rats with the intact baroreceptors.' 0 ' 2 In those studies, bilateral vagotomy may have abolished ANP-induced inhibition of lumbar and renal sympathetic nerve activity, which suggests that ANP activates vagal afferents and thus inhibits sympathetic nerve activity. Furthermore, Imaizumi et al have shown that reflex increases in renal and lumbar sympathetic nerve activity do not occur during hypotension caused by ANP even in rats with the vagi sectioned and with intact arterial baroreceptors.' 2 The latter results have suggested that arterial baroreflex control of sympathetic nerve activity is also altered by ANP. They also have shown that ANP does not alter the slope that relates changes in arterial pressure and those in lumbar sympathetic nerve activity during rapid changes in arterial pressure caused by phenylephrine or nitroglycerin. 12 Thus, it appears that ANP lowers the set-point pressure but does not alter the slope of the stimulus-response curve of arterial baroreflex control of sympathetic nerve activity. 12 To explore the mechanisms by which ANP may alter arterial baroreceptor function, in this study we examined the interrelationship of arterial pressure, afferent aortic nerve activity, and the aortic diameter during stepwise decreases in arterial pressure caused by a-human ANP (a-hANP), a circulating form of ANP, and the results were compared with those obtained with sodium nitropmsside (SNP). We also examined the interrelationship of these variables during rapid increases or decreases in arterial pressure caused by phenylephrine or nitroglycerin, respectively, under intravenous infusion of saline, a-hANP, or SNP.
Materials and Methods
Experiments were done in adult male New Zealand White rabbits weighing 2.2-3.2 kg. The animals were anesthetized initially with thiamylal sodium (25 mg/kg i.v.) followed by a-chloralose (60 mg/kg i.v.). Supplemental doses of a-chloralose (10-20 mg/kg) were given hourly. Pancuronium bromide (0.5-1.0 mg i.v.) was given to eliminate muscular activity. After endotracheal intubation, the animals were ventilated artificially with room air supplemented with oxygen at a tidal volume of 10 ml/kg and at a frequency of 20-25 cycles/min. Arterial blood gases and pH were measured at intervals, and the ventilatory rate was adjusted to maintain pH between 7.40 and 7.55, PacO2 between 25 and 35 mm Hg, and PaO2 in excess of 100 mm Hg. The left femoral artery was cannulated into the aorta with PE 90 tubing for the measurement of arterial pressure, and bilateral femoral veins were cannulated with PE 90 tubings for the administration of drugs. The arterial cannula was connected to a pressure transducer (Toyo Baldwin, TMI, Tokyo, Japan). Arterial pressure and heart rate, which was triggered by arterial pulsation, were continuously monitored and recorded. Body temperature was maintained at 37°-40° C by external warming.
Recording and Quantification of Aortic Nerve Activity
A midline incision was made in the neck. Under a dissecting microscope, the left aortic depressor nerve was identified, separated from surrounding connective tissues by fine forceps, cut cranially, desheathed, and covered with mineral oil for subsequent recording of action potentials from the nerve. The nerve was placed on silver/silver chloride bipolar electrodes. The amplified signals then were fed into an oscilloscope (SS-5710, Iwatsu, Japan) so that the signals could be viewed, into an audio amplifier so that changes in nerve traffic could be detected by audible signal, and into a nerve traffic analyzer (DPA100D, Dia Medical System Co., Tokyo, Japan), which exceeded a preselected level (just above the noise) so that the spikes could be counted. Each spike that crossed the lower window discriminator level triggered a voltage step that was independent of spike amplitude. These voltage steps were then integrated by the nerve traffic analyzer, which was digital in design and could integrate linearly at instantaneous spike frequencies of up to 10 kHz. The raw electroneurogram and the integrated output from the spike counter were displayed on a recorder. It was confirmed that there was no nerve traffic activity after the nerve was crushed distally to the recording site.
Measurements of Aortic Diameter
After thoracotomy, a pair of miniature piezoelectric crystals (10 MHz, Murata, Tokyo, Japan) with a diameter of 2 mm and weighing 12 mg were glued to the adventitia of the ascending aorta near the aortic arch with a thin layer of instant glue for recording aortic diameter. The crystals were connected to an ultrasonic dimension system (UDM-5C, MECC, Japan), and the aortic diameter was measured by a technique of ultrasonic transit time measurement. 13 
Experiment 1
In 10 rabbits with intact arterial and cardiac receptors, changes in aortic nerve activity were examined during stepwise decreases in arterial pressure caused by the intravenous infusion of a-hANP or SNP. Sixty minutes were allowed for stabilization after completion of surgical procedures. First, SNP was infused intravenously at a rate of 1, 2, 3, or 5 /ng/kg/min for 15 minutes for each dose, which caused stepwise decreases in arterial pressure. Arterial pressure and aortic nerve activity were recorded continuously. After discontinuation of SNP, we waited for at least an hour. After arterial pressure and aortic nerve activity returned to the control levels, a-hANP was infused intravenously at a rate of 0.1, 0.2, 0.5, or 1.0 /ng/kg/min for 15 minutes for each dose, 1415 which caused stepwise decreases in arterial pressure. Arterial pressure and aortic nerve activity were stable at least during the last 5 minutes of infusion of each dose of SNP or a-hANP. The data before and during the last minute of infusion of each dose of SNP or a-hANP were used for later analysis.
Experiment 2
In eight rabbits with intact arterial and cardiac receptors, we examined changes in aortic diameter during stepwise decreases in arterial pressure caused by the intravenous infusion of a-hANP or SNP. Arterial pressure was decreased in stepwise fashion by the intravenous infusion of SNP or a-hANP as described in Experiment 1. The time course of the experiments was the same as in Experiment 1. In four of eight rabbits, we recorded aortic nerve activity and the aortic diameter simultaneously during stepwise decreases in arterial pressure caused by SNP or a-hANP. In these four rabbits, the order of the drugs was alternated. The data before and during the last minute of the infusion of each dose of SNP or a-hANP were used for later analysis. Figure 1 demonstrates simultaneous recordings of arterial pressure, aortic nerve activity, and the aortic diameter.
Experiment 3
In five rabbits, we examined changes in aortic nerve activity and aortic diameter simultaneously during stepwise decreases in arterial pressure caused by SNP or a-hANP after sinoaortic denervation and bilateral vagotomy. Sinoaortic denervation was performed by bilateral section of the aortic nerves and the cervical sympathetic chains, by interruption of all nerves and vascular structures that coursed between the internal and external carotid artery, and by removal of the adjacent adventitia in the region of the carotid sinus. Completeness of sinoaortic denervation was ensured before bilateral vagotomy by the absence of changes in heart rate with the increase in arterial pressure caused by the intravenous injection of phenylephrine. The distal portion of sectioned left aortic nerves was used for recording of aortic nerve activity. We waited for 1 hour after sinoaortic denervation and bilateral vagotomy before beginning the experiments. The time course of the experiments was the same as in Experiments 1 and 2, but the order of the drugs was alternated. The data before and during the last minutes of the infusion of each dose of SNP or a-hANP were used for later analysis.
Experiment 4
In nine rabbits with intact arterial and cardiac receptors, we examined changes in aortic nerve activity as arterial pressure was rapidly increased or decreased by the infusion of phenylephrine .g/kg/min) or nitroglycerin (10-50 /xg/kg/min), respectively, during the infusion of saline, SNP, or a-hANP. Phenylephrine or nitroglycerin raised or lowered mean arterial pressure by 20-30 mm Hg within 60 seconds. 16 Arterial pressure and aortic nerve activity were recorded continuously. First, changes in aortic nerve activity in response to rapid changes in arterial pressure caused by phenylephrine or nitroglycerin were determined during the infusion of saline (0.2 ml/min). After completion of the study during saline infusion, we waited for 30 minutes. SNP was then infused at a rate of 2-3 /xg/ kg/min for 15 minutes, which lowered mean arterial pressure by about 10 mm Hg. During the last several minutes of SNP infusion, arterial pressure was rapidly changed by phenylephrine or nitroglycerin while aortic nerve activity was continuously recorded. After completion of the study during SNP infusion, we waited for at least an hour, by which time arterial pressure and aortic nerve activity had returned to baseline values. The study with phenylephrine or nitroglycerin was then repeated during saline infusion. Thirty minutes after completion of the study performed during saline infusion, a-hANP was infused at a rate of 0.3-0.5 /ng/kg/min for 15 minutes, which lowered mean arterial pressure by about 10 mm Hg. The study with phenylephrine or nitroglycerin was done during the last several minutes of a-hANP infusion.
Experiment 5
In four rabbits with intact arterial and cardiac receptors, we examined changes in the aortic diameter during rapid changes in arterial pressure during the infusion of SNP or a-hANP. Rapid changes in arterial pressure were produced by the infusion of phenylephrine or nitroglycerin as in Experiment 4. Arterial pressure, aortic nerve activity, and the aortic diameter were recorded simultaneously in these rabbits throughout the experiment. The doses of SNP and a-hANP as well as the durations of the infusion were the same as in Experiment 4. First, changes in the aortic diameter and aortic nerve activity in response to rapid changes in arterial pressure caused by phenylephrine or nitroglycerin were determined during the last several minutes of SNP infusion. We waited for at least an hour after completion of the study performed during SNP infusion. a-hANP infusion was then initiated, and the study with phenylephrine or nitroglycerin was repeated during the last several minutes.
Statistical Analysis
In Experiments 1, 2, and 3, comparisons between control values before SNP and those before a-hANP were made by paired t test. Analysis of variance was used to determine statistical significance of changes made by SNP or a-hANP. Comparisons between the magnitudes of changes made by SNP and those made by a-hANP were first examined by analysis of variance and then the Bonferroni's multiple comparisons tests were used to determine the location of significance. The relation between changes in systolic arterial pressure and those in aortic nerve activity during infusion of SNP was compared with that during infusion of a-hANP by analysis of covariance. Similarly, the relation between changes in systolic arterial pressure and in the systolic aortic diameter during infusion of SNP was compared with the relation between changes during infusion of a-hANP by analysis of covariance.
In Experiment 4, the slope of the linear relation between changes in systolic arterial pressure and changes in aortic nerve activity was calculated by the least-squares method. The correlation coefficient was greater than 0.88. Comparisons between the slope during the infusion of SNP or a-hANP and during the infusion of saline and between the slope during the infusion of SNP and during the infusion of a-hANP were made by paired t test.
All values are expressed as mean±SEM, and p<0.05 was considered statistically significant. (Table 1) Baseline values in arterial pressure, aortic nerve activity, and heart rate before a-hANP did not differ from those before SNP. SNP or a-hANP caused the stepwise decreases in systolic, diastolic, and mean arterial pressure. The magnitudes of stepwise decreases in systolic, diastolic, and mean arterial pressure caused by a-hANP did not differ from those by SNP. Aortic nerve activity did not significantly change during hypotension caused by a-hANP, whereas it decreased during hypotension caused by SNP (p<0.01). The relation between changes in systolic arterial pressure and percentage changes in aortic nerve activity during stepwise decreases in arterial pressure caused by a-hANP was significantly different from that during hypotension caused by SNP (p<0.01, Figure 2 ). In addition, heart rate did not significantly change during hypotension caused by a-hANP, but it increased during hypotension caused by SNP (p<0.01).
Results

Changes in Aortic Nerve Activity in Rabbits With Intact Baroreceptors
Changes in Aortic Diameter in Rabbits With
Intact Baroreceptors ( Table 2 ) Baseline values of arterial pressure and aortic diameter before a-hANP did not differ from those before SNP. Resting arterial pressures tended to be lower and the magnitudes of decreases in arterial pressures caused by SNP and a-hANP tended to be smaller in Experiment 2 as compared with those in Experiment 1, presumably because the chest was open in Experiment 2 animals. The aortic diameter did not change during stepwise decreases in arterial pressure caused by a-hANP, whereas it decreased dose dependently during hypotension caused by SNP (/?<0.01). The relation between changes in systolic arterial pressure and changes in systolic aortic diameter during hypotension caused by a-hANP was significantly different from 
FIGURE 3. Relation between changes in systolic arterial pressure (SBP) and changes in the systolic aortic diameter (sysAoD) (n=8). The systolic aortic diameter decreased with the reduction in systolic arterial pressure during the infusion of sodium nitroprusside, whereas it did not decrease during the infusion of a-human atrial natriuretic peptide despite comparable hypotension
that during hypotension caused by SNP (p<0.01, Figure 3 ). It also was noted that magnitudes of pulsatile changes in aortic diameter decreased during hypotension caused by a-hANP (p<0.01), whereas it increased during hypotension caused by SNP(p<0.01).
In four of eight rabbits, aortic nerve activity and the aortic diameter were simultaneously recorded during infusions of SNP and a-hANP. The relation between changes in aortic nerve activity and in systolic aortic diameter during infusion of SNP or a-hANP is shown in Figure 4A . Changes in aortic nerve activity and in systolic aortic diameter were linearly related during infusion of SNP but not during infusion of a-hANP. Aortic nerve activity and systolic aortic diameter did not significantly change during the infusion of a-hANP. (Table 3) Baseline arterial pressure, aortic nerve activity, and the aortic diameter before a-hANP did not differ from those before SNP. Decreases in arterial pressures caused by a-hANP were less than those caused by SNP (/><0.01) in rabbits with sinoaortic denervation and bilateral vagotomy. These findings are in contrast with those in rabbits with intact baroreceptors in which a-hANP and SNP in the same doses used in rabbits with denervated baroreceptors caused comparable decreases in arterial pressure (Tables 1 and 2 ). Aortic nerve activity and the aortic diameter did not significantly change during hypotension caused by a-hANP, whereas they decreased during hypotension caused by SNP (p<0.01). When values at comparable decreases in arterial pressure were compared (a-hANP, 0.2 /ig/ kg/min vs. SNP 1 fig/kg/mm; a-hANP, 1.0/xg/kg/ min vs. SNP, 2 /ig/kg/min), changes in aortic nerve activity and aortic diameter with a-hANP were significantly less than changes with SNP (p<0.01).
Changes in Aortic Nerve Activity and Aortic Diameter in Rabbits With Sinoaortic Denervation and Bilateral Vagotomy
In these rabbits, aortic nerve activity and aortic diameter were simultaneously recorded during the infusions of SNP and a-hANP. The relation between changes in aortic nerve activity and in systolic aortic diameter during infusion of SNP or a-hANP is shown in Figure 4B . Changes in aortic nerve activity and in systolic aortic diameter were linearly related during infusion of SNP, whereas aortic nerve activity and systolic aortic diameter did not significantly change during the infusion of a-hANP. Figure 5 demonstrates the relation between changes in systolic arterial pressure and those in aortic nerve activity during rapid changes in arterial pressure caused by phenylephrine or nitroglycerin under saline, SNP, or a-hANP infusion. Mean 
Changes in Aortic Nerve Activity During Rapid Changes in Arterial Pressure Caused by Phenylephrine or Nitroglycerin
. Relation between changes in the systolic aortic diameter (sysAoD) and percentage changes in aortic nerve activity (ANA) in rabbits in which these variables were simultaneously recorded. The results in rabbits with intact arterial and cardiac baroreceptors (n=4) are shown in A and those in rabbits with baroreceptors denervated (n=5) in B. There was a linear relation between changes in aortic nerve activity and those in the systolic aortic diameter during the infusion of sodium nitroprusside in rabbits with intact baroreceptors as well as in those with baroreceptors denervated.
On the other hand, during the irtfusion of a-human atrial natriuretic peptide, neither the systolic aortic diameter nor aortic nerve activity changed significantly from control values in rabbits with intact baroreceptors as well as in rabbits with baroreceptors denervated. arterial pressure during saline infusion before SNP (90±2 mm Hg) did not differ from that during saline infusion before a-hANP (93±3 mm Hg). SNP and a-hANP lowered mean arterial pressure to 78 ±3 mm Hg and 82±3 mm Hg, respectively. The magnitude of the decrease in mean arterial pressure caused by a-hANP did not differ from that by SNP. The regression line relating changes in systolic arterial pressure and percentage changes in aortic nerve activity during rapid changes in arterial pressure caused by phenylephrine or nitroglycerin was not altered by SNP or a-hANP. Figure 6 demonstrates the relation between changes in systolic arterial pressure and those in the systolic aortic diameter during rapid changes in arterial pressure caused by phenylephrine or nitroglycerin under SNP or a-hANP infusion («=4).
Changes in Aortic Diameter During Rapid Changes in Arterial Pressure Caused by Phenylephrine or Nitroglycerin
Mean arterial pressure during infusion of SNP (82±4 mm Hg) did not differ from that during infusion of a-hANP (78±5 mm Hg). The relation between these two variables was linear with the curve flattened above baseline arterial pressure. The relation under SNP infusion did not differ from that under a-hANP infusion.
Discussion
The major finding of this study is that aortic nerve activity did not decrease during stepwise decreases in arterial pressure caused by a-hANP, whereas comparable decreases in arterial pressure caused by SNP were accompanied by expected decreases in aortic nerve activity. Thus, during the infusion of a-hANP, the inhibitory inputs from aortic baroreceptors to the vasomotor center in the brainstem remained unchanged despite hypotension. This result may account for the previous finding that reflex increases in lumbar and renal sympathetic nerve activity did not occur during hypotension caused by a-hANP in animals with intact arterial baroreceptors and bilateral vagotomy. 12 To explore the mechanisms by which aortic nerve activity during hypotension caused by a-hANP was maintained at the level similar to that at control, we examined changes in aortic diameter during stepwise decreases in arterial pressure caused by a-hANP and SNP. Aortic diameter did not change during hypotension caused by a-hANP, whereas it decreased with SNP. It is generally considered that arterial baroreceptors respond to the deformation or strain of the vessel walls in which the baroreceptors are located. 17 Aars has demonstrated that changes in the aortic diameter are closely correlated with changes in aortic nerve activity. 18 Therefore, these results suggest that aortic nerve activity did not decrease during hypotension caused by a-hANP because aortic diameter did not change.
The finding that aortic diameter remained unchanged during hypotension caused by a-hANP suggests that a-hANP dilated the ascending thoracic aorta in rabbits. To our knowledge, this is the first demonstration of aortic vasodilatation caused by a-hANP in intact animals. This finding is in agreement with the previous reports that ANP causes relaxation of the aortic strip of rats in vitro 19 and that there are receptors for ANP in the rat aorta. 12 On the other hand, the pressure-dependent decreases in aortic diameter were observed during hypotension caused by SNP. Thus, we consider that the difference in the effects of these two drugs on aortic baroreceptor function has resulted from the difference in the vasodilator effects on the aorta.
We must consider the possibility that mechanisms other than aortic vasodilatation might have contributed to altered responses of aortic diameter and aortic nerve activity to hypotension during infusion a-hANP. First, changes in aortic diameter and aortic nerve activity in response to a-hANP might be different from those in response to SNP if the hypotensive effect of a-hANP is mediated in part by its central actions to decrease sympathetic nerve activity. However, it is unlikely that a-hANP alters control of sympathetic nerve activity by acting on the central nervous system. A recent study in our laboratory has shown that a-hANP, administered intravenously or into the cerebroventricle, does not alter sympathetic nerve activity or sympathetic nerve responses to graded electrical stimulation of aortic depressor nerves in rabbits with sinoaortic denervation and bilateral vagotomy (S. Suzuki et al, unpublished observation). It has been shown that intracerebroventricular a-hANP inhibits the pressor response to intracerebroventricular angiotensin II. 20 -21 However, this effect of intracerebroventricular a-hANP appears to result from the inhibition of the central effect of angiotensin II. 22 Several studies have shown that intracerebroventricular a-hANP does not alter baseline arterial pressure. 2021 Second, we should consider the possibility that the difference in the effects of a-hANP and SNP on the aortic diameter and aortic nerve activity might have been caused by the difference in the compensation by other receptors. 23 This possibility needs to be considered since a-hANP may alter arterial and cardiac receptor function. 9 -12 To examine this possibility, the experiments were repeated in rabbits with sinoaortic denervation and bilateral vagotomy. The results in rabbits with baroreceptors denervated were similar to those in rabbits with intact baroreceptors, which indicates that the difference in aortic baroreceptor response to a-hANP and SNP can not be accounted for by the difference in the compensation by other receptors. The results in rabbits with sinoaortic denervation and vagi sectioned also indicate that the magnitudes of hypotension caused by SNP were greater than those caused by a-hANP. In rabbits with intact baroreceptors, the same doses of SNP and a-hANP produced comparable hypotensive effects. The latter findings are in agreement with the previous finding that a-hANP inhibits reflex increases in sympathetic nerve activity in response to hypotension. 1012 Thoren et al have suggested that atriopeptin may sensitize the cardiac receptors and thus augment inhibitory influence of vagal afferents on sympathetic nerve activity. 10 We considered the possibility that a-hANP might have sensitized aortic baroreceptors and thus have prevented the decrease in aortic nerve activity during hypotension. To investigate this possibility, we examined the relation between changes in the aortic diameter and those in aortic nerve activity in rabbits in which these two variables were simultaneously recorded (Figure 4 ). If a-hANP had sensitized aortic baroreceptors, the levels of aortic nerve activity during the infusion of a-hANP would have been higher than those expected by changes in the aortic diameter. However, such findings were not observed in rabbits with intact baroreceptors nor in those with baroreceptors denervated (Figure 4 ). Thus, we consider it unlikely that a-hANP sensitizes aortic baroreceptors, although this possibility can not be excluded completely.
Finally, we considered the possibility that aortic baroreceptors might have been acutely reset by the exposure to lower arterial pressure, and thus, the expected decreases in aortic nerve activity did not occur during hypotension caused by a-hANP. 2+ - 27 However, this is unlikely because hypotension with SNP was accompanied by decreases in aortic nerve activity. The magnitudes and duration of hypotension were comparable during the infusions of a-hANP and SNP.
The other important finding in this study is that changes in aortic nerve activity and the aortic diameter in response to rapid changes in arterial pressure caused by phenylephrine or nitroglycerin were not altered by a-hANP. These results indicate that a-hANP dilates the aorta but does not alter aortic responses to changes in arterial pressure caused by other means. We consider that aortic baroreceptor responses to rapid changes in arterial pressure caused by phenylephrine and nitroglycerin were unaltered by a-hANP because aortic responses to rapid changes in arterial pressure were not altered. These findings can account for the finding in a previous study that a-hANP does not alter the relation between changes in arterial pressure and those in lumbar sympathetic nerve activity during rapid changes in arterial pressure caused by phenylephrine and nitroglycerin. 12 In summary, the results of this study suggest that a-hANP dilates the aorta so that aortic nerve activ-ity does not decrease despite hypotension during the infusion of a-hANP. a-hANP does not alter the responses of the aortic diameter and aortic nerve activity to rapid changes in arterial pressure caused by phenylephrine and nitroglycerin. These findings may explain the mechanisms by which a-hANP alters arterial baroreflex control of renal and lumbar sympathetic nerve activity.
